XML 100 R64.htm IDEA: XBRL DOCUMENT
v3.25.1

Mergers and Acquisitions - Soin Pharmaceuticals (Details) $ in Thousands |  |  | 1 Months Ended | 12 Months Ended
--- | --- | --- | --- | ---
Jan. 24, 2024 USD ($) tranche | Dec. 28, 2022 USD ($) | Feb. 28, 2025 USD ($) | Mar. 30, 2024 USD ($) | Dec. 28, 2024 USD ($)
Dr. Soin |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Payments for legal settlements |  |  |  |  | $ 150
Dr. Soin | Subsequent Event |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Payments for legal settlements |  |  | $ 350 |  |
Soin Therapeutics LLC |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Number of tranches | tranche | 3 |  |  |  |
Soin Therapeutics LLC | Business Acquisition, Consideration, Tranche One |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Cash payment tendered for contingent liability |  |  |  | $ 100 |
Soin Therapeutics LLC | Business Acquisition, Consideration, Tranche Two |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Aggregate principal amount |  |  |  | 100 |
Soin Therapeutics LLC | Business Acquisition, Consideration, Tranche Three |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Aggregate principal amount |  |  |  | $ 2,800 |
Soin Therapeutics LLC | Soin Agreement Convertible Tranche One |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Business acquisition, shares issued, fair value | $ 3,000 | $ 2,700 |  |  |
Soin Therapeutics LLC | Soin Agreement Convertible Tranche Two |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Business acquisition, shares issued, fair value | $ 10,000 | 8,000 |  |  |
Soin Therapeutics LLC | Soin Agreement Convertible Tranche Three |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Business acquisition, shares issued, fair value |  | $ 3,900 |  |  | $ 17,000

X
- Definition Number Of Tranches + References No definition available. + Details
Name: | alts_NumberOfTranches
Namespace Prefix: | alts_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5 + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 8 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 7 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479668/805-30-25-5 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 8 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 30 -Paragraph 7 -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of cash outflow, made soon after acquisition date of business combination, to settle contingent consideration liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 13 -Subparagraph (d) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of cash paid for the settlement of litigation or for other legal issues during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (g) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25 + Details
Name: | us-gaap_PaymentsForLegalSettlements
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=alts_DrSoinMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=alts_SoinTherapeuticsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=alts_BusinessAcquisitionConsiderationTrancheOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=alts_BusinessAcquisitionConsiderationTrancheTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=alts_BusinessAcquisitionConsiderationTrancheThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=alts_SoinAgreementConvertibleTrancheOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=alts_SoinAgreementConvertibleTrancheTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=alts_SOINAgreementConvertibleTrancheThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |